WCK 5153Alternative Names: WCK-5153
Latest Information Update: 03 Jun 2016
At a glance
- Originator Wockhardt
- Class Antibacterials; Azabicyclo compounds; Small molecules
- Mechanism of Action Penicillin-binding protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Bacterial infections
Most Recent Events
- 09 Apr 2016 Preclinical trials in Bacterial infections in USA (IV)